Athersys shares rebound somewhat since falling by two-thirds on clinical trial results

Athersys plans to ask shareholders to approve a reverse stock split of its shares.

Previous Covid may have peaked in Oregon but health leaders urge vigilance
Next Dallas-based Steward Health Care and HCA call off deal for five Utah hospitals after FTC complaint

No Comment

Leave a reply

Your email address will not be published.